Northwestern University
Chicago, Illinois, United States
Dr. Ramsey-Goldman was appointed as an Assistant Professor of Medicine at the University of Pittsburgh after she completed her rheumatology training. She relocated to Chicago where she continued as an Assistant Professor of Medicine at Northwestern University where she rose through the ranks to Professor followed by an appointment as an endowed professor, Solovy Arthritis Research Society Research Professor of Medicine. Subsequently, she received the Gallagher Research Professorship in Rheumatology . She is a leader in clinical investigation locally, nationally and internationally. Her research program examines risk factors to minimize complications in lupus and pregnancy outcomes, studies genetic risk factors for disease severity/susceptibility; collaborates on investigations studying pathogenesis of disease; develops disease classification criteria, flare assessments, nephritis guidelines, assessment of physical activity as it related to patient outcomes (fatigue), and developed community education programs for lupus awareness, improving diversity in lupus clinical trial participation, and vaccine hesitancy in RMDs. Dr. Ramsey-Goldman has been held numerous volunteer positions for the ACR including Chair of SOTA, Professional Meetings Committee, COE. and COIN. She has served on the Board of Directors, is a member of the Membership & Awards Committee, was an associate & co-editor for A&R, she served on the Scientific Advisory Council for the RRF, and is an ACR Master.
16S53: Abstracts: Reproductive Issues in Rheumatic Disorders
Saturday, November 16, 2024
1:00 PM – 2:30 PM Eastern Time
No financial relationships with ineligible companies to disclose
17S30: Navigating Rheumatic Diseases During the Menopause Transition
Sunday, November 17, 2024
1:00 PM – 2:00 PM Eastern Time
Disclosure(s): Ampel Solutions: Consultant (Ongoing); biogen: Consultant (Ongoing); Bristol-Myers Squibb(BMS): Consultant (Ongoing); Calabetta: Consultant (Ongoing); Exagen: Consultant (Ongoing); Immunocor: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Merck/MSD: Consultant (Terminated, January 1, 2024)